323 related articles for article (PubMed ID: 28857179)
1. Comparative effectiveness of antiepileptic drugs in patients with mesial temporal lobe epilepsy with hippocampal sclerosis.
Androsova G; Krause R; Borghei M; Wassenaar M; Auce P; Avbersek A; Becker F; Berghuis B; Campbell E; Coppola A; Francis B; Wolking S; Cavalleri GL; Craig J; Delanty N; Koeleman BPC; Kunz WS; Lerche H; Marson AG; Sander JW; Sills GJ; Striano P; Zara F; Sisodiya SM; Depondt C;
Epilepsia; 2017 Oct; 58(10):1734-1741. PubMed ID: 28857179
[TBL] [Abstract][Full Text] [Related]
2. Comparative persistence of antiepileptic drugs in patients with epilepsy: A STROBE-compliant retrospective cohort study.
Lai EC; Hsieh CY; Su CC; Yang YK; Huang CW; Lin SJ; Setoguchi S
Medicine (Baltimore); 2016 Aug; 95(35):e4481. PubMed ID: 27583857
[TBL] [Abstract][Full Text] [Related]
3. Comparative effectiveness of 10 antiepileptic drugs in older adults with epilepsy.
Arif H; Buchsbaum R; Pierro J; Whalen M; Sims J; Resor SR; Bazil CW; Hirsch LJ
Arch Neurol; 2010 Apr; 67(4):408-15. PubMed ID: 20385905
[TBL] [Abstract][Full Text] [Related]
4. A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial.
Marson AG; Appleton R; Baker GA; Chadwick DW; Doughty J; Eaton B; Gamble C; Jacoby A; Shackley P; Smith DF; Tudur-Smith C; Vanoli A; Williamson PR
Health Technol Assess; 2007 Oct; 11(37):iii-iv, ix-x, 1-134. PubMed ID: 17903391
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors for time to treatment failure and time to 12 months of remission for patients with focal epilepsy: post-hoc, subgroup analyses of data from the SANAD trial.
Bonnett L; Smith CT; Smith D; Williamson P; Chadwick D; Marson AG
Lancet Neurol; 2012 Apr; 11(4):331-40. PubMed ID: 22377180
[TBL] [Abstract][Full Text] [Related]
6. Pharmacoresistance with newer anti-epileptic drugs in mesial temporal lobe epilepsy with hippocampal sclerosis.
Pohlen MS; Jin J; Tobias RS; Maheshwari A
Epilepsy Res; 2017 Nov; 137():56-60. PubMed ID: 28941835
[TBL] [Abstract][Full Text] [Related]
7. New antiepileptic drugs.
Bourgeois BF
Arch Neurol; 1998 Sep; 55(9):1181-3. PubMed ID: 9740111
[TBL] [Abstract][Full Text] [Related]
8. New antiepileptic drugs in pediatric epilepsy.
Hwang H; Kim KJ
Brain Dev; 2008 Oct; 30(9):549-55. PubMed ID: 18328657
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ;
Neurology; 2004 Apr; 62(8):1252-60. PubMed ID: 15111659
[TBL] [Abstract][Full Text] [Related]
10. Newer antiepileptic drugs. Towards an improved risk-benefit ratio.
Patsalos PN; Sander JW
Drug Saf; 1994 Jul; 11(1):37-67. PubMed ID: 7917080
[TBL] [Abstract][Full Text] [Related]
11. Monostars: an aid to choosing an antiepileptic drug as monotherapy.
Brodie MJ
Epilepsia; 1999; 40 Suppl 6():S17-22; discussion S73-4. PubMed ID: 10530678
[TBL] [Abstract][Full Text] [Related]
12. Long-term Effectiveness of Antiepileptic Drug Monotherapy in Partial Epileptic Patients: A 7-year Study in an Epilepsy Center in China.
Zhu F; Lang SY; Wang XQ; Shi XB; Ma YF; Zhang X; Chen YN; Zhang JT
Chin Med J (Engl); 2015 Nov; 128(22):3015-22. PubMed ID: 26608980
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed?
Johannessen SI; Tomson T
Clin Pharmacokinet; 2006; 45(11):1061-75. PubMed ID: 17048972
[TBL] [Abstract][Full Text] [Related]
14. New pharmacotherapies for pediatric seizures.
Pellock JM
Pediatr Ann; 2004 Jun; 33(6):385-91. PubMed ID: 19449513
[No Abstract] [Full Text] [Related]
15. Pharmacokinetics and interaction profile of topiramate: review and comparison with other newer antiepileptic drugs.
Johannessen SI
Epilepsia; 1997; 38 Suppl 1():S18-23. PubMed ID: 9092953
[TBL] [Abstract][Full Text] [Related]
16. Antiepileptic drugs management and long-term seizure outcome in post surgical mesial temporal lobe epilepsy with hippocampal sclerosis.
Pimentel J; Peralta AR; Campos A; Bentes C; Ferreira AG
Epilepsy Res; 2012 Jun; 100(1-2):55-8. PubMed ID: 22336897
[TBL] [Abstract][Full Text] [Related]
17. Anticonvulsant drugs in primary headaches prophylaxis.
Frediani F
Neurol Sci; 2004 Oct; 25 Suppl 3():S161-6. PubMed ID: 15549529
[TBL] [Abstract][Full Text] [Related]
18. Importance of neuropsychological and clinical features to predict seizure control in medically treated patients with mesial temporal epilepsy and hippocampal sclerosis.
Grau-López L; Jiménez M; Ciurans J; Cáceres C; Becerra JL
Epilepsy Behav; 2017 Apr; 69():121-125. PubMed ID: 28242475
[TBL] [Abstract][Full Text] [Related]
19. [Empirical evidence for the use of anticonvulsants in personality disorders].
Sieberer M; Emrich HM
Fortschr Neurol Psychiatr; 2009 Mar; 77(3):133-8. PubMed ID: 19283647
[TBL] [Abstract][Full Text] [Related]
20. Anticonvulsant drug therapies.
Howland RH
J Psychosoc Nurs Ment Health Serv; 2005 Jun; 43(6):17-20. PubMed ID: 16018130
[No Abstract] [Full Text] [Related]
[Next] [New Search]
